These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 1955565
1. Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP. Nakamura M, Kuroki M, Kira J, Itoyama Y, Shiraki H, Kuroda N, Washitani Y, Nakano S, Nagafuchi S, Anzai K. J Neuroimmunol; 1991 Dec; 35(1-3):167-77. PubMed ID: 1955565 [Abstract] [Full Text] [Related]
2. Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy. Kitze B, Usuku K, Izumo S, Nakamura M, Shiraki H, Ijichi S, Yashiki S, Fujiyoshi T, Sonoda S, Osame M. J Neurol; 1996 May; 243(5):393-400. PubMed ID: 8741079 [Abstract] [Full Text] [Related]
3. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1. Jacobson S, Reuben JS, Streilein RD, Palker TJ. J Immunol; 1991 Feb 15; 146(4):1155-62. PubMed ID: 1704032 [Abstract] [Full Text] [Related]
8. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S. J Exp Med; 1993 Jun 01; 177(6):1567-73. PubMed ID: 8496677 [Abstract] [Full Text] [Related]
9. Standardisation of Western blotting to detect HTLV-1 antibodies synthesised in the central nervous system of HAM/TSP patients. Ribeiro LC, Gonçalves CC, Slater CM, Carvalho SM, Puccioni-Sohler M. Mem Inst Oswaldo Cruz; 2013 Sep 01; 108(6):730-4. PubMed ID: 24037195 [Abstract] [Full Text] [Related]
10. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera. Desgranges C, Souche S, Vernant JC, Smadja D, Vahlne A, Horal P. AIDS Res Hum Retroviruses; 1994 Feb 01; 10(2):163-73. PubMed ID: 8198868 [Abstract] [Full Text] [Related]
11. Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon. Takatani M, Crispim ME, Fraiji N, Stefani MM, Kiesslich D. Rev Inst Med Trop Sao Paulo; 2017 Apr 03; 59():e5. PubMed ID: 28380116 [Abstract] [Full Text] [Related]
17. Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: an isotype and subclass analysis. Dekaban GA, King EE, Arp J, Palker TJ, Rice GP. Scand J Immunol; 1994 Aug 03; 40(2):171-80. PubMed ID: 8047838 [Abstract] [Full Text] [Related]